Is this your firm? Get featured or correct your listing →
At a glance
Sanofi Ventures appears in 3 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was OMass Therapeutics' $310M Series C round (Oct 15, 2026). It co-invests most often with Janus Henderson Investors.
Recent changes
- Oct 15, 2026Oct 15, 2026Invested in OMass Therapeutics (Series C, $310M) ValueSpectrum
- Aug 4, 2026Aug 4, 2026Invested in QuantHealth (Series B, $45M) HIT Consultant
Portfolio
6 totalRecent Investment Activity
4Track record: led 0 and participated in 3 of 3 tracked venture rounds · 3 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | OMass Therapeutics | Series C | Participated | $310M | — | Bain Capital Life SciencesLeadunverifiedForbionLeadunverifiedGoogle Ventures (GV)unverifiedNorthpond VenturesunverifiedSanofi VenturesunverifiedBritish Business BankunverifiedJanus Henderson InvestorsunverifiedNovo HoldingsSynconaOxford Science EnterprisesSV Health Investors+2 more | ValueSpectrum |
| Aug 11, 2026 | Epicrispr Biotechnologies | Series C | Participated | $90M | — | Janus Henderson InvestorsLeadunverifiedFidelity InvestmentsunverifiedCormorant Asset ManagementunverifiedSanofi VenturesunverifiedOctagon Capital | Epicrispr Biotechnologies |
| Aug 4, 2026 | QuantHealth | Series B | Participated | $45M | — | Pulse story | |
| Jul 24, 2026 | Scribe Therapeutics | IPO | Participated | $155.5M (incl. private placement) | — | Scribe Therapeutics |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionLatest Pulse
- Oct 15, 2026OMass Therapeutics Raises $310M Series C For Rare DiseaseOxford biotech OMass Therapeutics raised an oversubscribed $310 million Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings to push its lead GPCR drug candidate through Phase 2.→
- Aug 4, 2026QuantHealth Raises $45M to Simulate Drug TrialsQuantHealth raised a $45M Series B led by Qumra Capital to expand AI simulation of clinical trials before patients enroll, a platform already used by 12 of the world's top 20 pharma companies.→
Sanofi Ventures FAQ
What companies has Sanofi Ventures invested in?
Sanofi Ventures' portfolio includes OMass Therapeutics, Epicrispr Biotechnologies, Latigo Biotherapeutics, Attovia Therapeutics, QuantHealth, Scribe Therapeutics.
Who does Sanofi Ventures co-invest with most?
In the rounds Value Add tracks, Sanofi Ventures most often invests alongside Janus Henderson Investors (2 shared deals), 5AM Ventures (1 shared deal), Andreessen Horowitz (1 shared deal), Ascenta Capital (1 shared deal), Bain Capital Life Sciences (1 shared deal).
Sources & methodologyshow
- Scribe Therapeuticsprimary source1 fact
- Epicrispr BiotechnologiesValue Add VC data1 fact
- HIT ConsultantValue Add VC data1 fact
- ValueSpectrumValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.